| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 753 |
| 1 | ETANERCEPT | 398 |
| 2 | METHOTREXATE SODIUM | 384 |
| 3 | METHOTREXATE | 344 |
| 4 | PANITUMUMAB | 337 |
| 5 | OMEPRAZOLE MAGNESIUM | 237 |
| 6 | PREDNISONE | 233 |
| 7 | FLUOROURACIL | 230 |
| 8 | FLUOROURACIL CREAM, 0.5% | 230 |
| 9 | OMEPRAZOLE | 213 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PANITUMUMAB | 337 | 0.0209 |
| 1 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 68 | 0.0149 |
| 2 | CLINDAMYCIN PHOSPHATE | 68 | 0.0123 |
| 3 | VANCOMYCIN HYDROCHLORIDE | 91 | 0.0109 |
| 4 | GRISEOFULVIN | 3 | 0.0103 |
| 5 | MEGNESIUM OXIDE | 4 | 0.0096 |
| 6 | DACOMITINIB | 6 | 0.0080 |
| 7 | IODIXANOL | 28 | 0.0077 |
| 8 | TERBINAFINE HYDROCHLORIDE TABLET | 55 | 0.0076 |
| 9 | INFLIXIMAB-DYYB | 26 | 0.0075 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 719 |
| 1 | Corticosteroid [EPC] | 687 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 642 |
| 3 | Epidermal Growth Factor Receptor Antagonist [EPC] | 477 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 372 |
| 5 | Proton Pump Inhibitor [EPC] | 362 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 318 |
| 7 | Benzodiazepine [EPC] | 296 |
| 8 | Platinum-based Drug [EPC] | 292 |
| 9 | Kinase Inhibitor [EPC] | 284 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Tubulin Inhibiting Agent [EPC] | 3 | 0.0103 |
| 1 | Epidermal Growth Factor Receptor Antagonist [EPC] | 477 | 0.0101 |
| 2 | Photoactivated Radical Generator [EPC] | 1 | 0.0078 |
| 3 | Allylamine Antifungal [EPC] | 55 | 0.0076 |
| 4 | Interleukin-5 Antagonist [EPC] | 5 | 0.0073 |
| 5 | Macrolide Antibacterial [EPC] | 5 | 0.0049 |
| 6 | Provitamin D2 Compound [EPC] | 140 | 0.0047 |
| 7 | Interleukin-17A Antagonist [EPC] | 167 | 0.0045 |
| 8 | Gamma Secretase Inhibitor [EPC] | 3 | 0.0033 |
| 9 | Radiographic Contrast Agent [EPC] | 75 | 0.0029 |